Puma Biotechnology Inc (PBYI) soared 10.03 in the last month: It’s impossible to believe the numbers

A new trading day began on Monday, with Puma Biotechnology Inc (NASDAQ: PBYI) stock price up 10.03% from the previous day of trading, before settling in for the closing price of $5.78. PBYI’s price has ranged from $2.13 to $5.79 over the past 52 weeks.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Annual sales at Healthcare sector company slipped by -1.58% over the past five years. With a float of $37.00 million, this company’s outstanding shares have now reached $41.18 million.

Puma Biotechnology Inc (PBYI) Insider Updates

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Puma Biotechnology Inc is 22.23%, while institutional ownership is 54.58%. The most recent insider transaction that took place on Jan 03, was worth 185,698. In this transaction President and CEO of this company sold 41,396 shares at a rate of $4.49, taking the stock ownership to the 6,936,947 shares. Before that another transaction happened on Jan 03, when Company’s Chief Financial Officer sold 15,682 for $4.49, making the entire transaction worth $70,348. This insider now owns 128,666 shares in total.

Puma Biotechnology Inc (PBYI) Performance Highlights and Predictions

In its latest quarterly report, released on 9/29/2023, the company reported earnings of $0.12 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

Puma Biotechnology Inc (NASDAQ: PBYI) Trading Performance Indicators

Here are Puma Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.32. Likewise, its price to free cash flow for the trailing twelve months is 12.53.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.07, a number that is poised to hit 0.30 in the next quarter and is forecasted to reach 0.31 in one year’s time.

Technical Analysis of Puma Biotechnology Inc (PBYI)

Puma Biotechnology Inc (NASDAQ: PBYI) saw its 5-day average volume 0.53 million, a positive change from its year-to-date volume of 0.43 million. As of the previous 9 days, the stock’s Stochastic %D was 92.77%. Additionally, its Average True Range was 0.35.

During the past 100 days, Puma Biotechnology Inc’s (PBYI) raw stochastic average was set at 98.83%, which indicates a significant increase from 97.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.31% in the past 14 days, which was lower than the 70.55% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.55, while its 200-day Moving Average is $3.56. Nevertheless, the first resistance level for the watch stands at $6.63 in the near term. At $6.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.40. If the price goes on to break the first support level at $5.86, it is likely to go to the next support level at $5.37. Assuming the price breaks the second support level, the third support level stands at $5.09.

Puma Biotechnology Inc (NASDAQ: PBYI) Key Stats

With a market capitalization of 302.55 million, the company has a total of 47,571K Shares Outstanding. Currently, annual sales are 228,030 K while annual income is 2 K. The company’s previous quarter sales were 56,120 K while its latest quarter income was 5,800 K.